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Abstract
Background: Most sleep bruxism (SB) episodes are accompanied by an increase in sympathetic 
tone and heart rate (HR).
Objectives: To characterize heart rate (HR) changes in relation to rhythmic masticatory muscle 
activities (RMMAs) in SB patients. 
Methods: Polysomnographic recordings were performed on 10 SB patients and 11 normal 
controls. The duration of movement events, amplitude and duration of HR increases, and time to 
reach HR peak associated with RMMAs and limb movements (LMs) were determined and the 
relationships of the parameters of HR increases with types of movements and RMMAs were 
analyzed.
Results: All of the parameters of HR increases associated with the three types of movements 
(RMMAs, RMMAs + LMs and LMs) and masseter activities (phasic, tonic and mixed) were 
significantly different (Two way ANOVA, P<0.001 for all) in both SB patients and controls. The 
duration of RMMAs/LMs was positively correlated with the parameters (SB patients: A
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R2=0.24-0.85, P<0.0001; Controls: R2=0.23-0.68, P<0.0001). The amplitude of HR increases was 
also positively correlated with respiration changes in the SB patients (R2=0.3258, P<0.0001) and 
controls (R2=0.09469, P<0.05). The proportions of phasic RMMAs associated with awakenings, 
microarousals and no cortical arousals were significantly different and so were the proportions of 
tonic and mixed RMMAs (Friedman’s tests, P<0.05-0.001).
Conclusions: The HR increases associated with RMMAs may be intrinsic to the cortical arousal 
response and autonomic activation, and differences in HR increases associated with different types 
of movements and RMMAs might be related to the changes in respiration and differences in 
cortical arousal levels. 
Keywords: sleep bruxism; rhythmic masticatory muscle activities; limb movements; cortical 
arousal; heart rate; respiration
Introduction
Sleep bruxism, a masticatory muscle activity during sleep, is characterized by rhythmic 
(phasic) or non-rhythmic (tonic) and not a movement disorder or sleep disorder in otherwise 
healthy individuals1. SB prevalence rate has been reported about 14-20%2 in children and 8-12% 
in adolescents and adults with a decrease with age3. Most SB patients complain of tooth wear, 
locked jaw, temporomandibular pain and temporal headache. Previous studies showed 
psychological (e.g. stress and anxiety) and genetic factors as well as smoking, esophageal reflux, 
drugs (such as selective serotonin reuptake inhibitors) might induce occurrence of SB4 but the 
etiology of SB is not fully clear. Although there are several types of treatments for SB patients5, 
most of them are only used to prevent the teeth and associated structures from being further 
damaged and none of them could effectively decrease the occurrence of SB without causing severe 
side effects. Therefore, more research is required to explore pathophysiologic mechanisms of SB.
SB episodes have been shown to be associated with changes in electroencephalographic 
(EEG) activities, sympathetic tone, heart rate (HR), blood pressure6,7. Several studies have showed 
that urinary catecholamine levels in SB patients were significantly higher than those in normal A
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controls 8,9, which is similar to with previous findings that higher levels of catecholamines in 
patients with hypertension or CHF10-12. It raises the possibility that SB might be associated with 
cardiovascular diseases. Indeed, a recent study even suggested a close relationship between SB 
and cardiovascular diseases by showing a higher occurrence of SB in cardiopathic patients than in 
non-cardiopathic patients13. However, the pathophysiological mechanisms underlying the SB are 
largely unknown.
Increased sympathetic activity was reported to start before SB onset, followed by an increase 
in EEG activities and HR/arterial blood pressure6,7. This highlights association of change in the 
sympathetic activity and HR increases associated with SB episodes or rhythmic masticatory 
muscle activities (RMMAs). In addition, rhythmic masticatory muscle activities (RMMAs) /SB 
episodes are often accompanied by limb movements (LMs) 14,15 and most of the LMs occur before 
the onset SB episodes 15. Moreover, previous studies demonstrated 14,16,17 that the increase in HR 
started several tens of seconds before or after the onset of periodic leg movements (PLMS) 16,18. 
These previous findings suggest that HR increases may be associated with LMs in addition to 
RMMAs/SB episodes. Indeed, recent study from our laboratory showed the HR increases occurred 
with RMMAs and LMs19. Given above, it would be interesting to know whether there were any 
differences between HR increases associated with isolated RMMAs, RMMAs accompanied with 
LMs (RMMAs + LMs) and LMs, between HR increases associated with different types of 
RMMAs. Therefore, the aim of this study was to examine HR changes in relation to different 
types of movements (isolated RMMAs, RMMAs +LMs, isolated LMs) and different types of 
RMMAs/SB episodes in patients with SB.
Materials and methods
Subjects
Twenty-one volunteers from Nanchang University, including 10 SB patients [4 males and 6 
females with ages of 18–24 years] and 11 normal controls [5 males and 6 females with ages of 20–A
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25 years] without any family history of cardiovascular diseases before 65 years old were recruited 
for the study. Every subject had a full dentition and no one had any psychiatric, medical (e.g. 
temporomandibular disorder) or sleep disorders such as sleep insomnia, sleep apnea and periodic 
leg movements. In the past six months, no one has used any alcohol, cigarettes, coffee, drugs or 
psychostimulants. All SB subjects were chosen based on the following criteria: 1) tooth grinding 
more than three days per week during the last six months, 2) complaints of facial muscle pain and 
morning headache, 3) masseter and/or temporalis muscle hypertrophy diagnosed by clinical 
examination, directed interview, and muscle palpation20 as well as presence of tooth wear 
(flattened occlusal and incisal surfaces without any sign of erosion)21, 22,23, and 4) two or more 
episodes of grinding with noise per night as well as presence of at least four RMMA episodes and 
25 bursts of masseter electromyographic (EMG) activities per hour of sleep during 
polysomnographic examination22,24. All subjects were provided with informed consent and they 
were free to withdraw any time.
Polysomnographic sleep recording
All polysomnographic recordings were carried out at the Sleep Center of the Jiangxi Metal 
Hospital. The first night was used for subjects to adapt to the laboratory environment, confirm SB 
and exclude sleep or sleep-related disorders such as periodic leg movements, sleep apnea, and 
rapid eye movement (REM) sleep behavioral disorders. The data from the polysomnographic 
recordings in the second night were used for further confirmation of SB and data analysis 
described below. Polysomnographic recordings of EEG (F3-A2, F4-A1, C3-A2, C4-A1, O1-A2, 
O2-A1), electrocardiographic (ECG) and electrooculographic (EOG) activities as well as thoracic 
and abdominal respiration, nasal air flow, body posture, and capillary oxygen saturation (SpO2) in 
index finger or thumb were performed15,19,25. In addition, EMG activities from mylohyoid, 
bilateral masseter and limb muscles (bilateral gastrocnemius and tibialis anterior muscle, and 
bilateral flexor and extensor carpi radialis) were also recorded. Infrared cameras and video 
recorders were used to monitor the movements in orofacial area, limbs and other parts of the body A
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to exclude non-specific oral activities such as lip sucking and swallowing, and to confirm the 
presence of tooth grinding and limb movements during data analysis.
Data Analysis and Statistics
All the data were initially analyzed with the Pro Fusion PSG 3 Software (Compumedics 
Limited, Abbotsford, Australia) and then with Spike 2 (Version 8.07, CED, Cambridge, UK) 
based on the criteria established by the American Association of Sleep Medicine (AASM) 22. 
SB-related masseter EMG activities were defined as masseter EMG activities that were two times 
above the background and SB episodes were classified as phasic (at least three consecutive 0.25 to 
2.0 s long masseter EMG bursts), tonic (masseter EMG burst lasting longer than 2.0 s) and mixed 
type (a mixture of two types of masseter muscle activities). EMG activities in limb muscles were 
considered to LM-related when they were 8 μV higher than the background with duration longer 
than 0.5s. LMs and RMMAs were considered to be related each other only if a time overlap 
existed between them. Transient cortical arousals (at least 3 s) were scored as previously 
described26 and divided into microarousals (mAR, 3–15 s) and awakenings (AW, longer than 15 s, 
but less than 60 s) 27,28. When any RMMAs/LMs occurred during wakefulness or started in sleep 
but ended in wakefulness, the data were excluded. If cortical arousal lasted shorter than 3 s, it was 
considered as no cortical arousal (NA).
RMMAs/LMs related HR increases were defined as the HR that increased above two 
standard deviations (SD) of the baseline HR (Fig. 1) and there was a time overlap between 
RMMAs/LMs and HR increases. Since the onset of HR increases occurred less than 10 s before 
the SB episodes15, a period of 10 s stable HR (10-20 s before the onset of RMMAs/LMs) was used 
to calculate mean baseline value and SD as previously described19. The onset and offset of the HR 
increases were defined as the time points when HR increased above and fell below the mean plus 
2 times SD, respectively. Then, duration of HR increases (i.e. duration between the onset and 
offset of HR increases) was determined. The amplitude of HR increases [peak HR value - A
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(baseline mean +2SD)] and time to reach peak HR (interval between the onset of HR increases and 
time point of peak HR) were calculated as previously described19.
The change in respiratory amplitude was calculated by the amplitude of respiration during 
RMMAs/LMs (difference between the highest and lowest points of nasal airflow pressure) minus 
the average amplitude of the five breathing cycles before the onset of the respiratory change. 
The statistical analyses were performed by using Graph Pad Prism (Version 7, San Diego, 
California, USA), SPSS (Version 22, Armonk, NY, USA) and Sigmaplot (Version 14.0, San Jose, 
California, USA). The differences between SB patients and controls were assessed by χ2 test, t-test 
or Wilcoxon rank-sum test wherever appropriate. Two way analysis of variance (ANOVA) with 
post hoc Holm-Sidak tests were used to analyze HR increases associated with different types of 
movements and RMMAs in both SB patients and controls. The relationships between the 
parameters of HR increases (i.e. duration, amplitude and time to reach peak HR) and duration of 
the movement events of RMMAs/LMs, and between HR increases and respiration changes were 
analyzed by using liner correlation analyses. Association of different types of RMMAs with 
arousal levels was analyzed by Friedman’s tests with post hoc Wilcoxon rank-sum tests with 
Bonferroni corrections. All data were expressed as mean ± standard error of mean (SEM) unless 
indicated otherwise and P<0.05 was considered to be statistically significant.
Ethical approval:
The research protocol was reviewed and approved by the local Ethical Review Board at 
Jiangxi Mental Hospital (2017007) in accordance with the ethical standards of the Declaration of 
Helsinki. Prior to participation, informed consent was obtained from each subject.
Results
General sleep characteristics of the SB patients and the controlsA
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All general sleep variables from 10 SB patients and 11 controls were shown in Table 1. The 
total sleep time and the proportions of sleep time spent in different sleep stages in the SB patients 
were not significantly different from those in the controls (t-test, P>0.05). In addition, there was 
no significant difference in sleep efficiency between SB patients and controls (t-test, P>0.05). 
Nevertheless, the SB index for the SB patients was significantly higher (t-test, P<0.001) than that 
for the controls, and the microarousal and arousal indexes for the SB patients were significantly 
higher (Wilcoxon rank-sum test, P<0.01) than those for the controls, respectively. However, there 
were no significant differences in the apnea-hypopnea index (AHI), and periodic leg movement 
index (PLMI) between SB patients and controls (Wilcoxon rank-sum test, P>0.05).
Differences in HR increases associated with isolated RMMAs, RMMAs + LMs, and isolated 
LMs
The mean duration of HR increases per night in the SB patients (17.45 ± 2.37 min) was 
significantly longer (t-test, P<0.05) than that in the controls (11.10 ± 1.03 min). A total of 1027 
events (617 in the SB patients and 410 in the Controls) of HR increases associated with isolated 
RMMAs (43 and 23), RMMAs with a companion of LMs (RMMAs + LMs, 446 and 285), and 
isolated LMs (128 and 102) were analyzed. Two way ANOVA analyses showed that the 
amplitude and duration of HR increases, time to reach HR peak, and duration of movement events 
from the onset of RMMAs or LMs (whatever appeared first) to the offset of RMMAs or LMs 
(whatever ended last) were significantly different between types of movements [F(2, 
1021)=114.46, 116.64, 95.3 and 113.59, respectively. P<0.001 for all]. There were no significant 
differences between subjects [F(1, 1021)=0.22, 0.03, 0.16 and 0.24, respectively. P>0.05 for all) 
and mixed statistical results for their interactions [F(2, 1021)=4.22, 1.20, 1.59 and 0.44, 
respectively. P>0.05 for all except for amplitude of HR increases (P<0.05)].
Post hoc Holm-Sidak tests showed that the durations of movement events and HR increases, 
and time to reach HR peak associated with RMMAs + LMs were significantly longer than those A
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associated with isolated RMMAs (P<0.001) or isolated LMs (P<0.001) in both SB patients and 
controls (Fig. 2b-2d). In addition, in the controls, the amplitude of HR increases associated with 
RMMAs + LMs was significantly higher than that associated with isolated RMMAs (P<0.001) or 
isolated LMs (P<0.001), but there was no significant difference between the amplitudes of HR 
increases associated with isolated RMMAs and isolated LMs (P>0.05) (Fig. 2a). In contrast, in the 
SB patients, the amplitude of HR increases associated with RMMAs + LMs, and isolated RMMAs 
were both significantly higher than that associated with isolated LMs (P<0.001, P<0.01) and the 
amplitudes of HR increases associated with RMMAs + LMs were significantly higher (P<0.01) 
than those associated with isolated RMMAs (Fig. 2a).
Compared with the controls, time to reach HR peak and amplitude associated with RMMAs + 
LMs were significantly shorter (P<0.001) (Fig. 2c) and lower (P<0.001) (Fig. 2a) in the SB 
patients. There were not any other significant differences in the duration, amplitude and time to 
reach HR peak and duration of movement events associated with 3 different types of movements 
between SB patients and controls.
Correlation of the HR increases with duration of the events of RMMAs/LMs 
There were significantly positive correlations between the duration of the events of 
RMMAs/LMs and the amplitude of HR increases, between the duration of the events of 
RMMAs/LMs and the duration of HR increases, and between the duration of the events of 
RMMAs/LMs and the time to reach peak HR in both SB patients (R2=0.2361, 0.8464, and 0.5286, 
respectively, P<0.0001) and controls (R2=0.2265, 0.6807, and 0.5415, respectively, P<0.0001).
HR increases associated with different types of RMMAs
A total of 489 events of HR increases associated with RMMAs (phasic: 248, tonic: 85, and 
mixed: 156) in the SB patients and 308 (phasic: 115, tonic: 68, and mixed: 125) in the controls 
were analyzed (Fig. 3). χ2 test showed the percentage of three types of RMMAs was significantly A
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different (P=0.001) in the SB patients from that in the controls. The percentage of mixed type of 
RMMAs was significantly smaller (P=0.015) in the SB patients than that in the controls.
Two way ANOVA analyses showed significant differences in the amplitude and duration of 
HR increases, time to reach HR peak, and duration of movement events between types of masseter 
muscle activities [F(2, 791)= 41.33, 36.18, 27.70 and 28,06, respectively. P<0.001], and mixed 
statistical results between subjects [F(1, 791) =12.95, 2.21, 4.68 and 0.434, respectively. P<0.001, 
P<0.05 for amplitude and time to reach HR peak, respectively; P> 0.05 for the others] and for 
their interactions [F(2, 791)=2.796, 3.19, 1.21 and 2.77, respectively. P>0.05 for all except for the 
duration of HR increases (P<0.05)].
In the SB patients, as illustrated in Fig. 3, post hoc Holm-Sidak tests showed that the 
movement events associated with tonic RMMAs had a significantly shorter duration (P<0.01; 
P<0.001) and their related HR increases had a significantly shorter duration (P<0.01; P<0.001), 
shorter time to reach peak HR (P<0.05; P<0.001), and lower amplitude (P<0.01; P<0.001) 
compared with those associated with phasic and mixed RMMAs. Moreover, the duration of 
movement events, the amplitude and duration of HR increases, as well as the time to reach HR 
peak associated with mixed RMMAs were significantly longer (P<0.01), higher (P<0.001), longer 
(P<0.01) and longer (P<0.01), respectively, than those associated with phasic RMMAs.
In the controls, the movement events associated with mixed RMMAs had a significantly 
longer duration (P<0.001; P<0.001) (Fig. 3d) and their related HR increases had a significantly a 
longer duration (P<0.001; P<0.001) (Fig. 3b), longer time to reach HR peak (P<0.001; P<0.001) 
(Fig. 3c), and a higher amplitude (P<0.001; P<0.001) (Fig. 3a) compared with those associated 
with phasic and tonic RMMAs, respectively.
Compared with the controls, HR increases associated with mixed RMMAs in the SB patients 
had a significantly shorter duration (P<0.05) (Fig. 3b), lower amplitude (P<0.001) (Fig. 3a) and 
shorter time to reach HR peak (P<0.01) (Fig. 3c). There were not any other significant differences 
in the above parameters between SB patients and controls (P>0.05).A
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Association of different types of RMMAs with cortical arousal levels
In the SB patients, 36.94% (0-75%) (median, minimum-maximum), 50.48% (25-88%), and 
4.38% (0-22.22%) of phasic RMMAs and in the controls, 28.57% (0-75%), 71.43% (25-100%), 
and 0% (0-11.11%) of phasic RMMAs were associated with AW, mAR, and NA, respectively 
(Fig. 4). Friedman’s test showed a significant difference in proportion of phasic RMMAs 
associated with AW, mAR and NA (P<0.001 for both) in both SB patients and controls. Post hoc 
Wilcoxon rank-sum tests with Bonferroni corrections (the level of significance at 0.017) showed 
the proportions of phasic RMMAs associated with AW and mAR were significantly larger than 
those associated with NA in both SB patients (P=0.013 and P=0.005, respectively) and controls 
(P=0.008 and P=0.003, respectively).
In contrast, 2.27% (0-50%), 73.33% (33.33-100%), and 7.27% (0-44.44%) of tonic RMMAs 
in the SB patients and 33.33% (0-54.55%), 57.14% (0-75%) and 0% (0-100%) of the tonic 
RMMAs in the controls were associated with AW, mAR, and NA, respectively (Fig. 4). 
Friedman’s test showed a significant difference in the proportions of tonic RMMAs associated 
with AW, mAR and NA (P<0.01; P<0.05) in both SB patients and controls. Post hoc Wilcoxon 
rank-sum tests with Bonferroni corrections showed the proportions of tonic RMMAs associated 
with mAR were significantly larger (P=0.007 and P=0.007, respectively) than those associated 
with NA and AW in the SB patients and no significant difference in the proportions of tonic 
RMMAs associated with different cortical arousal levels in the controls. However, there was a 
trend of higher percentage of tonic RMMAs associated with mAR than that associated with AW in 
the controls although the difference did not reach a statistical significance (the level of 
significance at 0.017, P=0.028).
However, 45% (0-71.43%), 47.92% (28.57-100%), and 1.06% (0-25%) of the mixed 
RMMAs in the SB patients and 61.54% (50-100%), 38.46% (0-50%) and 0% (0-0%) of the mixed 
RMMAs in the controls were associated with AW, mAR, and NA, respectively (Fig. 4). A
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Friedman’s test showed significant differences in proportions of mixed RMMAs associated with 
AW, mAR and NA (P<0.01, P<0.001) in both SB patients and controls. Post hoc Wilcoxon 
rank-sum tests with Bonferroni corrections showed the proportions of mixed RMMAs associated 
with AW and mAR were significantly larger than those associated with NA in both SB patients 
(P=0.015 and P=0.005, respectively) and controls (P=0.003 and P=0.008, respectively). In 
addition, the proportions of mixed RMMAs associated with AW were significantly larger 
(P=0.008) than those associated with mAR in the controls.
The mixed RMMAs in the controls were more (Wilcoxon rank-sum test, P=0.013) frequently 
associated with AW and less (P<0.05) frequently associated with mAR than those in the SB 
patients. However, no significant difference (P>0.05) was found in the proportion of the phasic 
and tonic RMMAs associated with AW and mAR between SB patients and controls. Nevertheless, 
the phasic and mixed, not tonic RMMAs, in the SB patients were more (P<0.01 and P<0.05, 
respectively) frequently associated with NA than those in the controls. 
HR increases during RMMAs/LMs in relation with changes of respiration 
Although HR increases could occur before, during or after the onset of RMMA/LMs, they 
always occurred after the onset of respiratory changes (2.9293±0.2410 s and 2.6922±0.1837 s after 
the onset of the changes in respiration in the SB patients and controls, respectively). In addition, 
the amplitudes of HR increases and respiration changes were significantly correlated in both SB 
patients (R2=0.3258, P<0.0001) and controls (R2=0.09469, P<0.05). However, the time intervals 
between the onset of HR increases and changes in respirations were not significantly different 
between SB patients and controls (t-test, P>0.05). No apnea or hypopnea (decreases in SpO2 
≥3%) was observed during RMMAs/LMs. 
Discussion
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SB, a rhythmic (phasic) or non-rhythmic (tonic) masticatory muscle activity during sleep1 
affects a large proportion of population especially children 2,3. In the study, we have systemically 
investigated the relationships of different types of movements (i.e. isolated RMMAs, RMMAs + 
LMs and isolated LMs) and RMMAs with associated HR increases during sleep and found 
significant differences in the parameters of HR increases associated with different types of 
movements and RMMAs (Fig. 2 and 3). These findings might contribute to a better understanding 
of pathophysiology of SB.
The occurrence of RMMAs/SB has been shown to be related to activation of central and 
autonomic nervous systems. The transient cortical arousals and increased sympathetic activity 
contribute to the increase in cortical excitatory input to the central pattern generator (CPG) 
through the cortico-bulbar projection and occurrence of RMMAs/SB episodes29. Indeed, the 
increase in sympathetic activity was reported to start prior to the onset of SB episodes, followed 
by an increase in cortical alpha and theta wave electroencephalographic (EEG) activities, heart 
rate, and arterial blood pressure6,7. In addition, most of episodes of RMMAs/SB were shown to be 
associated with transient cortical arousals, and when transient cortical arousals appeared, episodes 
of RMMAs/SB more likely occurred with a companion with LMs in the previous studies15,30,31.
In the SB patients and normal subjects, some common features existed in HR increases 
associated with RMMAs/SB episodes. First, the durations of increased sympathetic activity and 
transient cortical arousals in association with RMMAs accompanied with LMs in the SB patients 
and normal controls may last longer than those related to isolated RMMAs or isolated LMs since 
the durations of RMMAs accompanied with LMs and the related HR increases were significantly 
longer than durations of isolated RMMAs and isolated LMs and their related increases in HR, 
respectively (Fig. 2). Also, all other parameters of HR increases associated with RMMAs + LMs 
were also significantly different from those associated with isolated RMMAs or isolated LMs. 
This might be due to a higher percentage of RMMAs + LMs associated with longer cortical 
arousals (e.g. AW) than isolated RMMAs or isolated LMs15. Second, the duration of movement 
events might be associated with duration and amplitude of HR increases19. Third, duration of A
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movement events and parameters of HR increases associated with mixed RMMAs were 
significantly different from those associated with phasic and tonic RMMAs, which might be due 
to a significantly higher proportion of mixed RMMAs associated with AW and longer duration of 
mixed RMMAs than that of tonic and phasic RMMAs, which was correlated with the parameters 
of HR increases associated with RMMAs19. Although previous studies have reported that the 
amplitude and frequency of RMMAs in SB patients were significantly higher than those in normal 
subjects32, there were no significant differences in the HR increases associated with the three 
different types of RMMAs between SB patients and controls. This might be due to the HR 
increases associated with RMMAs were correlated with the duration of RMMAs19. These similar 
findings in both SB patients and controls suggest genesis of RMMAs and increases in HR 
associated with RMMAs with or without a companion of LMs in both SB patients and normal 
controls might involve some common mechanisms. 
Although HR increases associated with RMMAs in the controls followed the similar pattern 
as in the SB patients, some distinct differences existed between HR increases associated with 
RMMAs in the SB patients and controls. First, HR increases associated with RMMAs 
accompanied with LMs in the controls were higher and lasted longer than those in the SB (Fig. 2). 
This might be due to stronger and longer stimulation was needed to activate the central nervous 
system to generate RMMAs accompanied with LMs in the controls than in the SB patients. 
Indeed, previous study reported that a much lower percentage of RMMAs could be evoked by 
peripheral stimulation in normal subjects than in SB patients although a similar percentage of 
transient cortical arousals could be evoked in both normal subjects and SB patients19 which 
suggests stronger and longer peripheral stimulation is needed to evoke occurrence of RMMAs in 
normal subjects (e.g. AW) so longer cortical arousals (e.g. AW) would be more likely to occur and 
the resulting cortical excitation would be more likely to spread to more areas of the CNS, which 
might include the part controls LMs. This is supported by our recent findings that there was a 
lower frequency of RMMAs and a higher percentage of RMMAs accompanied with LMs in the 
normal subjects than in the SB patients25 and that there was a higher proportion of RMMAs with a 
companion of LMs associated with AW in the normal subjects19 than in the SB patients. Second, A
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the parameters of HR increases associated with mixed RMMAs, but not with phasic and tonic 
RMMAs, in the SB patients were significantly different from those in the controls, which may be 
due to a lower (Wilcoxon rank sum test, P=0.013) proportion of mixed RMMAs associated with 
AW and a significantly higher (P<0.05 for both) proportion of mixed RMMAs associated with 
mAR and NA in the SB patients than those in the controls, and no significant difference (P>0.05) 
in the phasic and tonic RMMAs associated with AW between SB patients and controls. 
As HR increases, respiration changes occurring with RMMAs, might be a part of responses to 
changes in the cortical arousal levels associated with RMMAs19. However, SpO2 was slightly 
decreased (less than <3%) during RMMAs/LMs as the SB patients recruited for the study were 
otherwise healthy (e.g. without concomitant obstructive sleep apnea). As shown in the previous 
study19, the onset of HR increases in relation to the onset of RMMAs can be variable, which might 
be due to respiration changes associated with RMMAs. It has been shown HR increases associated 
with RMMAs/LMs always occurred after the onset of the changes in respiration and the 
parameters (e.g. amplitude) of HR increases was significantly correlated with the changes in 
respiration in the previous19 and current studies, which suggests HR increases associated with 
RMMAs were closely related to respiration changes.
In SB patients, sympathetic cardiac activity associated with RMMAs was significantly higher 
than that in normal controls although resting HR in SB patients was not higher than that in the 
normal controls33. In SB patients, RMMAs and their associated with HR increases occurred more 
often than those in normal controls (Table 1). In addition, the mean duration of HR increases in 
SB patients was significantly longer (P<0.05) than that in the control. The movements and their 
associated HR increases in SB patients may be related to an increase in stress. SB patients tend to 
feel more stressful at work and in their daily life 34 and have an increase in oxidative stress and 
anxiety 35, salivary cortisol 36 and urinary catecholamines 8,9. Stress or emotional responses might 
increase jaw movements as neurons in forebrain limbic nuclei including amygdala, in which some 
of neurons are innervated by corticotrophin-releasing factor immunopositive fibers, project to the 
mesencephalic nucleus, the trigeminal motor nucleus or to reticular regions around the motor A
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nucleus. Forebrain nuclei related to stress responses and autonomic control might influence the 
trigeminal motor neurons and consequently play a role in the physiopathology of SB37. Indeed, 
psychological counseling38 and relaxation therapies39 that could reduce exaggerated 
responsiveness to emotional or physical stress40 might be used in treatment of SB.
Previous6,41 and current studies have shown close relationships between occurrence of 
RMMAs/SB and sympathetic activation, so any approaches that can decrease sympathetic activity 
per se and reduce any stimulation that causes sympathetic excitation might be used to treat SB. For 
example, orthopedic appliances24 and occlusal adjustments42, which can reduce sympathetic 
activity related to oral somatosensory stimulation, and alpha2 receptor agonists (such as 
clonidine), which reduce sympathetic activity43-45, have been reported for treatment of SB. 
Clonidine (an α2 receptor agonist) has been shown to reduce SB index in SB patients by 61% even 
though it is not currently used for treatment of SB due to its blood pressure lowering effects 44. 
However, cause versus effect relationship between sympathetic excitation and occurrence of 
RMMAs cannot be established in the current study. A previous study showed there was a close 
relationship between SB and cardiovascular diseases13. However, it is unclear whether frequent 
movements associated with HR increases and arousals in SB patients during sleep increase 
cardiovascular vulnerability. Further studies of pathophysiological mechanisms of SB and possible 
influences of RMMAs/SB on cardiovascular vulnerability are needed. 
In short, we have studied HR increases in relation to different types of movements and 
RMMAs in the SB patients and normal controls. These data suggest the HR increases associated 
with RMMAs may be intrinsic to the cortical arousal response and autonomic activation, and 
difference in HR increases associated with different types of movements and RMMAs might be 
related to the changes in respiration and difference in cortical arousal levels associated with 
RMMAs. Inhibition of sympathetic activity or removal/reduction of any stimulation that causes 
sympathetic excitation might contribute to treatment effects in some therapies for SB.
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Conclusions
These data suggest the HR increases associated with RMMAs may be intrinsic to the cortical 
arousal response and autonomic activation, and differences in HR increases associated with 
different types of movements and RMMAs might be related to the changes in respiration and 
differences in cortical arousal levels.
Limitations of the study
The number of subjects used in the current study was relatively small, the ratios of male to 
female subjects in the groups of the SB patients and controls were not the same, and the age range 
was narrow. Further studies are required to examine larger groups of the SB patients and controls 
with equal ratios of female to male subjects in a wider age range. Since calculation of respiration 
was based on an indirect measure of air flow and estimation of nasal pressure from the PSG 
recordings, data interpretation should be made with caution.
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Table 1. Demographic and general sleep data of the study population
SB patients Controls P*
Sex
Male 4 5
Female 6 6
Age, yr 21.3±0.63 22.55±0.45 0.122
Sleep variables
Total sleep time, min 422.55±15.04 443.86±13.61 0.305
Sleep efficacy, % 91.33±2.08 91.20±1.25 0.957
Microarousal index, events/h 5.95 (3.31-16.36) 3.45 (1.92-6.45) 0.005
Arousal index, events/h 8.55 (6.40-18.10) 5.13 (2.85-8.30) 0.001
AHI, events/h 0.55 (0.30-4.97) 0.70 (0.21-4.80) 0.557
SB index, events/h 8.35±0.83 3.77±0.38 <0.001
PLMI, events/h 2.25 (0.45-8.50) 0.80 (0.00-4.41) 0.468
Sleep stage (%)
N1 6.98±1.20 8.23±0.90 0.410
N2 35.18±3.65 41.99±1.35 0.132
N3 31.89±2.30 26.58±2.17 0.110
REM 25.71±2.45 23.20±1.30 0.364
Values are expressed as mean ± standard error of mean (SEM) for variables with a normal 
distribution and median (minimum-maximum) for variables with a non-normal distribution. AHI: 
apnea-hypopnea index. N1-N3: non-rapid eye movement sleep stage 1-3. PLMI: periodic leg 
movements index. REM: rapid eye movement. SB: sleep bruxism. A
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* t-test or Wilcoxon rank-sum test.
Figure legends
Fig. 1. The raw data recorded from SB patients showing SB/RMMAs (a: Phasic, b: Tonic and c: 
Mixed type), LMs and their associated HR changes. SB: sleep bruxism; RMMAs: rhythmic 
masticatory muscle activities; LMs: limb movements; HR: heart rate; MASS: masseter muscle; 
MH: mylohyoid muscle; LUE: extensor carpi radialis of left forearm; LUF: flexor carpi radialis of 
left forearm; RUE: extensor carpi radialis of right forearm; RUF: flexor carpi radialis of right 
forearm; LLE: tibialis anterior muscle of left leg; LLF: gastrocnemius of left leg; RLE: tibialis 
anterior muscle of right leg; RLF: gastrocnemius of right leg. Horizontal bar: 10 s; Vertical bar: 20 
bpm for HR, 1 mV for electrocardiographic activities and 100 µV for all electromyographic traces.
Fig. 2. Differences in the amplitude (a), duration (b) of HR increase, time to reach HR peak (c) 
and duration of movement events (d) associated with RMMAs, RMMA+LMs and LMs in the SB 
patients and the controls. *P<0.05, **P<0.01 and ***P<0.001, post hoc Holm-Sidak tests. Errors 
represent one SEM. HR: heart rate; SB: sleep bruxism; RMMAs: rhythmic masticatory muscle 
activities; LMs: limb movements; SEM: standard error of mean.
Fig. 3. Differences in the amplitude (a), duration (b) of HR increases, time to reach HR peak (c) 
and duration of movement events (d) associated with phasic, tonic and mixed RMMAs in the SB 
patients and the controls. *P<0.05, **P<0.01 and ***P<0.001, post hoc Holm-Sidak tests. Error 
bars represent one SEM. HR: heart rate; SB: sleep bruxism; RMMAs: rhythmic masticatory 
muscle activities; SEM: standard error of mean. 
Fig. 4. Association of different types of RMMAs with changes in arousal levels. AW: awakenings; 
mAR: microarousal; NA: no arousal. n=10 for the SB patients and n=11 for the controls. The data A
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were expressed as median (minimum-maximum). *P<0.017, **P<0.003, post hoc Wilcoxon 
rank-sum tests with Bonferroni corrections. SB: sleep bruxism; RMMAs: rhythmic masticatory 
muscle activities; SEM: standard error of mean.
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